The Vaccine Research Institute (VRI), Laboratory of excellence, was established by the French National Agency for Research on AIDS and viral hepatitis (ANRS – France REcherche Nord&sud Sida-HIV Hépatites) and the University of Paris-Est Créteil (UPEC) to conduct research to accelerate the development of effective vaccines against HIV/AIDS, and (re)-emerging infectious diseases. The VRI’s structure strengthens the links between basic research and translational research, patients associations and the socio-ec
Our missions
The VRI’s scientific strategy, since its creation, has been organized into fully integrated research programs and supported with shared scientific, technological and administrative platforms.